Omnicell Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Omnicell wird ein jährliches Gewinn- und Umsatzwachstum von 116.1% bzw. 4.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 116.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 6.9% betragen.
Wichtige Informationen
116.1%
Wachstumsrate der Gewinne
116.8%
EPS-Wachstumsrate
| Medical Equipment Gewinnwachstum | 17.5% |
| Wachstumsrate der Einnahmen | 4.6% |
| Zukünftige Eigenkapitalrendite | 7.0% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 10 Sep 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Omnicell, Inc.'s (NASDAQ:OMCL) Price Is Right But Growth Is Lacking After Shares Rocket 49%
Aug 02
Is There Now An Opportunity In Omnicell, Inc. (NASDAQ:OMCL)?
Jul 11Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price
Jun 16Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt
May 25An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued
Mar 28Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues
Feb 29Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?
Feb 23Omnicell Is Building A Strong Moat
Feb 22Does Omnicell (NASDAQ:OMCL) Have A Healthy Balance Sheet?
Jan 15Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price
Dec 25Is Omnicell, Inc. (NASDAQ:OMCL) Trading At A 48% Discount?
Dec 06Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Slashed Next Year's Revenue Estimates By 14%
Nov 10Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 27% Undervaluation?
Sep 06Would Omnicell (NASDAQ:OMCL) Be Better Off With Less Debt?
Aug 08Why Omnicell, Inc. (NASDAQ:OMCL) Could Be Worth Watching
Jul 02A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)
Jun 08Investors Could Be Concerned With Omnicell's (NASDAQ:OMCL) Returns On Capital
Apr 29Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?
Apr 11At US$55.77, Is Omnicell, Inc. (NASDAQ:OMCL) Worth Looking At Closely?
Mar 23Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 42% Undervaluation?
Feb 28Returns On Capital Are Showing Encouraging Signs At Omnicell (NASDAQ:OMCL)
Jan 15We Think Omnicell (NASDAQ:OMCL) Can Stay On Top Of Its Debt
Jan 01Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 46% Undervaluation?
Nov 17Analysts Just Slashed Their Omnicell, Inc. (NASDAQ:OMCL) EPS Numbers
Nov 03Omnicell launches Specialty Pharmacy Services
Oct 11Omnicell (NASDAQ:OMCL) Seems To Use Debt Quite Sensibly
Sep 30Omnicell says advance services to drive profitable growth in long-run: Investor Day
Sep 20Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?
Sep 15Omnicell (NASDAQ:OMCL) Might Have The Makings Of A Multi-Bagger
Aug 31Omnicell reports Q2 earnings miss; reaffirms FY22 guidance and issues Q3 outlook
Aug 04Are Investors Undervaluing Omnicell, Inc. (NASDAQ:OMCL) By 41%?
Aug 03Omnicell Fails To Justify Inclusion In Long-Only, Equity-Focused Portfolio
Jul 21We Ran A Stock Scan For Earnings Growth And Omnicell (NASDAQ:OMCL) Passed With Ease
Jun 27Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?
Jun 13Omnicell's (NASDAQ:OMCL) Returns On Capital Are Heading Higher
May 30These 4 Measures Indicate That Omnicell (NASDAQ:OMCL) Is Using Debt Safely
May 05Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 1,202 | 30 | 61 | 122 | 4 |
| 12/31/2025 | 1,144 | 19 | 35 | 111 | 8 |
| 12/31/2024 | 1,091 | 2 | 29 | 117 | 8 |
| 6/30/2024 | 1,080 | -21 | 152 | 204 | N/A |
| 3/31/2024 | 1,103 | -21 | 165 | 218 | N/A |
| 12/31/2023 | 1,147 | -20 | 126 | 181 | N/A |
| 9/30/2023 | 1,186 | -34 | 165 | 225 | N/A |
| 6/30/2023 | 1,235 | -23 | 127 | 189 | N/A |
| 3/31/2023 | 1,268 | -18 | 48 | 107 | N/A |
| 12/31/2022 | 1,296 | 6 | 17 | 78 | N/A |
| 9/30/2022 | 1,309 | 48 | -5 | 55 | N/A |
| 6/30/2022 | 1,258 | 61 | 18 | 77 | N/A |
| 3/31/2022 | 1,199 | 72 | 98 | 158 | N/A |
| 12/31/2021 | 1,132 | 78 | 173 | 232 | N/A |
| 9/30/2021 | 1,070 | 80 | 195 | 249 | N/A |
| 6/30/2021 | 987 | 60 | 194 | 242 | N/A |
| 3/31/2021 | 914 | 35 | 164 | 218 | N/A |
| 12/31/2020 | 892 | 32 | 131 | 186 | N/A |
| 9/30/2020 | 891 | 38 | 86 | 144 | N/A |
| 6/30/2020 | 906 | 49 | 101 | 164 | N/A |
| 3/31/2020 | 924 | 69 | 85 | 144 | N/A |
| 12/31/2019 | 897 | 61 | 83 | 145 | N/A |
| 9/30/2019 | 860 | 54 | 98 | 158 | N/A |
| 6/30/2019 | 836 | 48 | 59 | 117 | N/A |
| 3/31/2019 | 807 | 38 | 55 | 112 | N/A |
| 12/31/2018 | 787 | 38 | 50 | 104 | N/A |
| 9/30/2018 | 772 | 54 | 8 | 61 | N/A |
| 6/30/2018 | 754 | 48 | -19 | 27 | N/A |
| 3/31/2018 | 747 | 44 | N/A | 16 | N/A |
| 12/31/2017 | 713 | 31 | N/A | 25 | N/A |
| 9/30/2017 | 688 | -1 | N/A | 45 | N/A |
| 6/30/2017 | 678 | -6 | N/A | 72 | N/A |
| 3/31/2017 | 670 | -9 | N/A | 56 | N/A |
| 12/31/2016 | 696 | 10 | N/A | 50 | N/A |
| 9/30/2016 | 651 | 8 | N/A | 54 | N/A |
| 6/30/2016 | 599 | 14 | N/A | 40 | N/A |
| 3/31/2016 | 539 | 24 | N/A | 44 | N/A |
| 12/31/2015 | 485 | 31 | N/A | 38 | N/A |
| 9/30/2015 | 476 | 32 | N/A | 37 | N/A |
| 6/30/2015 | 463 | 32 | N/A | 50 | N/A |
| 3/31/2015 | 455 | 31 | N/A | 75 | N/A |
| 12/31/2014 | 441 | 31 | N/A | 65 | N/A |
| 9/30/2014 | 425 | 28 | N/A | 49 | N/A |
| 6/30/2014 | 407 | 29 | N/A | 59 | N/A |
| 3/31/2014 | 395 | 27 | N/A | 52 | N/A |
| 12/31/2013 | 381 | 24 | N/A | 55 | N/A |
| 9/30/2013 | 365 | 23 | N/A | 53 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: OMCL wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.5%).
Ertrag vs. Markt: OMCL wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: OMCL wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: OMCLDie Einnahmen des Unternehmens (3.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.6% pro Jahr).
Hohe Wachstumseinnahmen: OMCLDie Einnahmen des Unternehmens (3.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: OMCLDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (6.9%).